Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Bibliographic Details
Published in:	Frontiers in Oncology
Main Authors:	Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Subjects:	SMAC mimetics LCL161 Gemcitabine plus Cisplatin therapy multidrug resistance cholangiocarcinoma acquired vulnerability
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1124912/full

Internet